Discovery Laboratories (DSCO) Proprietary Aerosol Drug Delivery Technology Showcased at the 2011 AdvaMed Annual Meeting
9/29/2011 10:28:12 AM
WARRINGTON, Penn., Sept. 29, 2011 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announced that its proprietary capillary aerosolization technology was selected for presentation at the 2011 Advancing Medical Technology Association (AdvaMed) Annual Meeting held September 26 – 28, 2011. The annual AdvaMed meeting brings together companies that produce medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed member companies produce nearly 90 percent of the health care technology purchased annually in the United States and more than 50 percent purchased annually around the world.
comments powered by